跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 976 条关于
“ND4-LHON”
全部
976
临床试验
469
药物
238
机构
24
资讯
245
去年
GenSight's Gene Therapy Shows Better Outcomes When Administered During Dynamic Phase of LHON Disease
9个月前
GenSight Biologics Secures French Regulatory Approvals for GS010/LUMEVOQ Gene Therapy in Rare Blindness Disease
10个月前
GenSight Biologics Secures FDA Authorization for Expanded Access Treatment of Rare Blinding Disease
去年
LUMEVOQ Gene Therapy Shows Sustained Vision Improvement in LHON Patients After 5 Years
去年
Lenadogene Nolparvovec Shows Sustained Vision Improvement in LHON Patients After 5 Years
去年
NICE Recommends First NHS Treatment for Rare Eye Disease LHON, Ending Access Disparity in England
去年
GenSight Biologics Successfully Transfers LUMEVOQ Manufacturing to Catalent for LHON Gene Therapy
6年前
Subthreshold Electrical Stimulation Shows Promise in LHON Treatment
去年
GenSight Biologics Secures French Regulatory Pathway for LUMEVOQ Gene Therapy in Rare Blindness Disease
2个月前
FDA Probes Sevoflurane-Linked Neurological Complications in Patients of Venezuelan Ancestry
第 1 页,共 25 页
上一页
下一页